Medical Advocates
HAART/ART
 
HAART/ART Failure

General Reports
Virological Failure
 Immunological Failure
Mortality/Risk Factors




 
 
HAART Main Page Main New/Newsworthy   Home Page    
Last Update:  May 14, 2008  
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
 
     Journal Papers, Abstracts, and Commentaries
 
  ARTICLE
 Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts.
Bisson GP, Gaolathe T, Gross R, et al 
PLoS ONE. 2008 Mar 5;3(3)
 Abstract
Virological Failure
     

      Journal Papers, Abstracts, and Commentaries

 
Predictors of Antiretroviral Treatment Failure in an Urban HIV Clinic.
Robbins GK, Daniels B, Zheng H, et al
 J Acquir Immune Defic Syndr. 2006 Nov 9;
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL TEXT PDF ARTICLE
 Current concepts in antiretroviral therapy failure.
Del Rio C.
 Top HIV Med. 2006 Aug-Sep;14(3):102-6.
 Paper

Immune Reconstitution and Predictors of Virologic Failure in Adolescents Infected through Risk
Behaviors and Initiating HAART: Week 60 Results from the PACTG 381 Cohort.
 Rudy BJ, Lindsey JC, Flynn PM, et al 
AIDS Res Hum Retroviruses. 2006 Mar;22(3):213-21.
 Abstract
 

     Conference Reports, Abstracts, and Posters

  Predictors of Virological Failure at 6 Months of Therapy in HIV-1-infected Patients
Starting HAART in Porto Alegre, Brazil
 S Tuboi, E Sprinz, L Harrison,  et al
12 CROI)
Abstract
 
Trends Over Time in Initial Virological Failure of First HAART: 1996 to 2002.
A Joint Cohort Analysis of 4143 Subjects
 F Lampe, J Gatell, S Staszewski, et al
(12 CROI)
Abstract
Poor Immunological Response/Immunological
Failure
     Journal Papers, Abstracts, and Commentaries
 
  Predictors of Immunological Failure after Initial Response to Highly Active
Antiretroviral Therapy in HIV-1-Infected Adults: A EuroSIDA Study.
Dragsted UB, Mocroft A, Vella S, et al 
J Infect Dis. 2004 Jul 1;190(1):148-55.
 Abstract
 
     Conference Reports, Abstracts, and Posters
 
  Predictors of poor immune response to highly active antiretroviral therapy in patients
with a sustained virologic response: The Australian HIV Observational Database
1999-2006
 Glenday K, Petoumenos K, Chuah J, et al
 (4th IAS Conference)
 Abstract
Mortality/Risk Factors
     
     Journal Papers, Abstracts, and Commentaries
 
 
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between
low-income and high-income countries.
 Braitstein P, Brinkhof MW, Dabis F, et a;
 Lancet. 2006 Mar 11;367(9513):817-24.
 Abstract
 
Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance
and abnormal laboratory markers.
 Sabin CA, Smith CJ, Youle M, et al,
AIDS. 2006 Jan 2;20(1):67-71.
 Abstract
 
Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy:
1984-2004.
Schneider MF, Gange SJ, Williams CM, et al
AIDS. 2005 Nov 18;19(17):2009-2018.
 Abstract
 
Mortality in Patients With Successful Initial Response to Highly Active Antiretroviral Therapy
Is Still Higher Than in Non-HIV-Infected Individuals.
van Sighem A, Danner S, Ghani AC, et al 
J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):212-218
 Abstract

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death:
a prospective cohort study.
Sterne JA, Hernan MA, Ledergerber B,  et al
 Lancet. 2005 Jul 30-Aug 6;366(9483):378-84.
 Abstract
 
Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific
antiretroviral drugs in the regimen.
 Olsen CH, Gatell J, Ledergerber B 
AIDS. 2005 Feb 18;19(3):319-330.
 Abstract
 
Causes of death among human immunodeficiency virus (HIV)-infected adults
in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers,
persistent role of AIDS.
 Lewden C, Salmon D, Morlat P, et al.
Int J Epidemiol. 2004 Nov 23;
Abstract

    
     Conference Reports, Abstracts, and Posters
 
 
Risk factors for early mortality on antiretroviral treatment in a rural hospital in Tanzania
 Johannessen A, Naman E, Matee M, et al
 (4th IAS Conference)
Abstract

Risk of AIDS and Death at Given HIV RNA and CD4 Count Levels, according to
Specific Antiretroviral Drugs in the CART Regimen
 C Holkmann-Olsen, J Gatell, B Ledergerber, et al
 (12 CROI)
Abstract

HIV and Non-HIV-related Deaths and Their Relationship to Immunodeficiency:
The D:A:D Study
 R Weber, N Friis-Møller, C Sabin, et al
(12 CROI)
Abstract
 
HIV Gender Differences in Morbidity and Mortality and the Effect of Aging
 S Hadrigan, M Miguez-Burbano, X Burbano,  et al
(12 CROI)
Abstract
 
Mortality Rates According to Initial HAART Regimen: A Collaborative Analysis of
2 Prospective Cohort Studies
 R Hogg, J Lundgren, D Costagliola, et al
(12 CROI)
Abstract

HAART Main Page Main New/Newsworthy   Home Page    

HAART/ART Failure